Response to the Letter regarding "Prolonged Cytokine Release Syndrome is Associated with Hypofibrinogenemia after CD19-Directed CAR T-Cell Therapy in Adult Patients with Relapsed/Refractory Lymphoma".

Jo T

Open source

DOI
10.1016/j.jtct.2026.09.027
Published
2026 Sep 17
Container
Transplantation and cellular therapy
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jtct.2026.09.027,
  title = {Response to the Letter regarding "Prolonged Cytokine Release Syndrome is Associated with Hypofibrinogenemia after CD19-Directed CAR T-Cell Therapy in Adult Patients with Relapsed/Refractory Lymphoma".},
  author = {Jo T},
  year = {2026},
  journal = {Transplantation and cellular therapy},
  doi = {10.1016/j.jtct.2026.09.027},
  url = {https://doi.org/10.1016/j.jtct.2026.09.027}
}

RIS

TY  - JOUR
TI  - Response to the Letter regarding "Prolonged Cytokine Release Syndrome is Associated with Hypofibrinogenemia after CD19-Directed CAR T-Cell Therapy in Adult Patients with Relapsed/Refractory Lymphoma".
AU  - Jo T
PY  - 2026
JO  - Transplantation and cellular therapy
DO  - 10.1016/j.jtct.2026.09.027
UR  - https://doi.org/10.1016/j.jtct.2026.09.027
ER  - 

APA

T, J. (2026). Response to the Letter regarding "Prolonged Cytokine Release Syndrome is Associated with Hypofibrinogenemia after CD19-Directed CAR T-Cell Therapy in Adult Patients with Relapsed/Refractory Lymphoma".. Transplantation and cellular therapy. https://doi.org/10.1016/j.jtct.2026.09.027

Source records